HDFC Pharma and Healthcare Fund vs DSP Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1383 Cr | ₹3138 Cr |
| Min Investment | ₹100 | ₹100 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹100 |
| Launch Date | 28 Sep 2023 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 18% |
| Expense Ratio | 2.17 | 1.92 |
| Manager | Dhruv Muchhal | Jay Kothari |
| ISIN Code | INF179KC1HL7 | INF740KA1LD8 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | 3.72% | 1.08% |
| 6 Month | 24.41% | 22.2% |
| 1 Year | 51.26% | 41.82% |
| 3 Year | - | 22.61% |
| 5 Year | - | 30.68% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 45.69% | 35.07% |
| 3 Year | - | 33.82% |
| 5 Year | - | 27.43% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 62.28% | 27.85% |
| 3 Year | - | 20.38% |
| 5 Year | - | 27.14% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | - | 14.69% |
| Sharp | - | 0.76% |
| Beta | - | 0.93% |
| Alpha | - | 3.36% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Dhruv Muchhal | Jay Kothari |
| Total AUM | ₹520687 Cr | ₹0 Cr |
| Fund Manage | 40 | 20 |
| HDFC Pharma and Healthcare Fund - Regular (G) | DSP Healthcare Fund - Regular Plan - Growth |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.98 | 17.61 |
| Small Cap | 33.12 | 41.87 |
| Large Cap | 32.5 | 22.07 |
| Mid Cap | 32.4 | 18.45 |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.98 | 17.61 |
| Pharmaceuticals & Biotechnology | 74.71 | 68.54 |
| Healthcare Services | 22.28 | 11.97 |
| Retailing | 1.03 | 0.41 |
| Insurance | - | 1.47 |
Top Comparisons
Nippon India Nifty 50 Value 20 Index Fund - Regular Plan - Growth Option
3Y Returns16.3%
HSBC NIFTY 50 INDEX FUND - Regular Growth
3Y Returns12.24%
Franklin India Dynamic Asset Allocation Fund of Funds-Growth
3Y Returns13.9%
BANDHAN Asset Allocation Fund - Regular Plan - Aggressive Plan - Growth
3Y Returns10.72%
Franklin India Corporate Debt Fund - Growth
3Y Returns5.7%
Invesco India Corporate Bond Fund - Growth
3Y Returns5.74%
Kotak Equity Hybrid - Growth
3Y Returns15.89%
Nippon India Equity Hybrid Fund - Growth Plan
3Y Returns15.59%